zami 1305 has been researched along with Experimental Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Presta, M; Ragnotti, G; Zavanella, T | 1 |
Fishbein, L; Jackson, CD | 1 |
1 review(s) available for zami 1305 and Experimental Neoplasms
Article | Year |
---|---|
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
1 other study(ies) available for zami 1305 and Experimental Neoplasms
Article | Year |
---|---|
Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305.
Topics: Adrenergic beta-Antagonists; Animals; Carcinogens; Female; Liver Neoplasms, Experimental; Neoplasms, Experimental; Propanolamines; Rats; Rats, Inbred Strains; Thyroid Gland; Thyroid Neoplasms | 1983 |